Does ORITAVANCIN DIPHOSPHATE Cause Erythema? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Erythema have been filed in association with ORITAVANCIN DIPHOSPHATE (Kimyrsa). This represents 6.2% of all adverse event reports for ORITAVANCIN DIPHOSPHATE.
17
Reports of Erythema with ORITAVANCIN DIPHOSPHATE
6.2%
of all ORITAVANCIN DIPHOSPHATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Erythema From ORITAVANCIN DIPHOSPHATE?
Of the 17 reports.
Is Erythema Listed in the Official Label?
Yes, Erythema is listed as a known adverse reaction in the official FDA drug label for ORITAVANCIN DIPHOSPHATE.
What Other Side Effects Does ORITAVANCIN DIPHOSPHATE Cause?
Multiple use of single-use product (102)
Chills (87)
Infusion related reaction (63)
Off label use (49)
Back pain (41)
Pruritus (36)
Dyspnoea (35)
Flushing (35)
Tremor (35)
Nausea (33)
What Other Drugs Cause Erythema?
ADAPALENE (38,965)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (30,872)
DUPILUMAB (10,877)
ADALIMUMAB (4,829)
ETANERCEPT (3,733)
AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (3,462)
INFLIXIMAB (2,919)
METHOTREXATE (2,835)
SECUKINUMAB (2,824)
RITUXIMAB (2,460)
Which ORITAVANCIN DIPHOSPHATE Alternatives Have Lower Erythema Risk?
ORITAVANCIN DIPHOSPHATE vs ORLISTAT
ORITAVANCIN DIPHOSPHATE vs ORNIDAZOLE
ORITAVANCIN DIPHOSPHATE vs ORPHENADRINE
ORITAVANCIN DIPHOSPHATE vs OSELTAMIVIR
ORITAVANCIN DIPHOSPHATE vs OSILODROSTAT